JP2018521674A5 - - Google Patents

Download PDF

Info

Publication number
JP2018521674A5
JP2018521674A5 JP2018504991A JP2018504991A JP2018521674A5 JP 2018521674 A5 JP2018521674 A5 JP 2018521674A5 JP 2018504991 A JP2018504991 A JP 2018504991A JP 2018504991 A JP2018504991 A JP 2018504991A JP 2018521674 A5 JP2018521674 A5 JP 2018521674A5
Authority
JP
Japan
Prior art keywords
encoding
gene
promoter
propionate
gene sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018504991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018521674A (ja
Filing date
Publication date
Priority claimed from PCT/US2016/032565 external-priority patent/WO2016183532A1/en
Priority claimed from PCT/US2016/037098 external-priority patent/WO2016201380A1/en
Application filed filed Critical
Priority claimed from PCT/US2016/044922 external-priority patent/WO2017023818A1/en
Publication of JP2018521674A publication Critical patent/JP2018521674A/ja
Publication of JP2018521674A5 publication Critical patent/JP2018521674A5/ja
Pending legal-status Critical Current

Links

JP2018504991A 2015-07-31 2016-07-29 プロピオネート異化を伴う障害を治療するために操作された細菌 Pending JP2018521674A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201562199445P 2015-07-31 2015-07-31
US62/199,445 2015-07-31
US201662336338P 2016-05-13 2016-05-13
USPCT/US2016/032565 2016-05-13
PCT/US2016/032565 WO2016183532A1 (en) 2015-05-13 2016-05-13 Bacteria engineered to treat a disease or disorder
US62/336,338 2016-05-13
US201662341320P 2016-05-25 2016-05-25
US62/341,320 2016-05-25
PCT/US2016/037098 WO2016201380A1 (en) 2015-06-10 2016-06-10 Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acid
USPCT/US2016/037098 2016-06-10
PCT/US2016/044922 WO2017023818A1 (en) 2015-07-31 2016-07-29 Bacteria engineered to treat disorders involving propionate catabolism

Publications (2)

Publication Number Publication Date
JP2018521674A JP2018521674A (ja) 2018-08-09
JP2018521674A5 true JP2018521674A5 (cg-RX-API-DMAC7.html) 2019-09-05

Family

ID=57944027

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018504991A Pending JP2018521674A (ja) 2015-07-31 2016-07-29 プロピオネート異化を伴う障害を治療するために操作された細菌

Country Status (5)

Country Link
EP (1) EP3328988A1 (cg-RX-API-DMAC7.html)
JP (1) JP2018521674A (cg-RX-API-DMAC7.html)
AU (1) AU2016303662A1 (cg-RX-API-DMAC7.html)
CA (1) CA2996535A1 (cg-RX-API-DMAC7.html)
WO (1) WO2017023818A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020005875A (es) 2017-12-05 2020-10-08 Bioplx Inc Métodos y composiciones para prevenir la infección microbiana.
CA3142608A1 (en) 2019-06-04 2020-12-10 Cocoon Biotech Inc. Silk-based products, formulations, and methods of use
CN112143689B (zh) * 2019-06-28 2023-01-03 中国科学院微生物研究所 重组恶臭假单胞菌株的构建及其在转化苏氨酸合成丙酸中的应用
WO2021137937A2 (en) * 2019-11-05 2021-07-08 The Trustees Of Columbia University In The City Of New York Engineered bacteria containing biosensors for precision targeting and containment
KR20220119030A (ko) 2019-12-02 2022-08-26 아스텔라스세이야쿠 가부시키가이샤 암의 처치에 이용하는 ny-eso-1 함유 인공 아주반트 벡터 세포
JP2023511305A (ja) * 2020-01-17 2023-03-17 ウニベルシテ カソリーク デ ルーベン 変化したエンベロープ完全性を有する遺伝子組換え細菌およびその使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
CA2353800A1 (en) 1998-12-02 2000-06-08 Trustees Of Boston University Gene networks for control of gene expression
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
US7731976B2 (en) 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
JP2014525266A (ja) * 2011-08-26 2014-09-29 マイクロバイオータ ダイアグノスティクス, エルエルシー 心欠陥を診断および治療する方法
EP2914274A4 (en) * 2012-11-01 2016-07-20 Sydney Children S Hospital Network Randwick And Westmead GENETICALLY MODIFIED PROBIOTIC FOR THE TREATMENT OF PHENYLKETONURIA
US9951340B2 (en) 2013-03-07 2018-04-24 The General Hospital Corporation Compositions and methods for bacterial delivery of polypeptides

Similar Documents

Publication Publication Date Title
JP2018515106A5 (cg-RX-API-DMAC7.html)
Lim et al. Engineered regulatory systems modulate gene expression of human commensals in the gut
Hegarty et al. Bacteriocin production: a relatively unharnessed probiotic trait?
Bron et al. Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract
Denou et al. Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysis
Bouillaut et al. Proline-dependent regulation of Clostridium difficile Stickland metabolism
Van Pijkeren et al. Exploring optimization parameters to increase ssDNA recombineering in Lactococcus lactis and Lactobacillus reuteri
Hemarajata et al. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri
Klotz et al. S-layer associated proteins contribute to the adhesive and immunomodulatory properties of Lactobacillus acidophilus NCFM
Fang et al. Allelic variation of bile salt hydrolase genes in Lactobacillus salivarius does not determine bile resistance levels
Paul et al. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats
Fleuchot et al. Rgg-associated SHP signaling peptides mediate cross-talk in Streptococci
AU2013327059B2 (en) Immunomodulatory minicells and methods of use
O'Shea et al. Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius
Ma et al. Global transcriptomic analysis and function identification of malolactic enzyme pathway of Lactobacillus paracasei L9 in response to bile stress
Sun et al. Accessing the inaccessible: molecular tools for bifidobacteria
US20150246085A1 (en) Genetically-Modified Probiotic for Treatment of Phenylketonuria
Hussain et al. Generation of lactose-and protease-positive probiotic Lacticaseibacillus rhamnosus GG by conjugation with Lactococcus lactis NCDO 712
JP2022061035A (ja) Il-10およびインスリンを安定的に発現する遺伝子改変された細菌
Wang et al. Functional role of oppA encoding an oligopeptide-binding protein from Lactobacillus salivarius Ren in bile tolerance
Corthier et al. Use of luciferase genes as biosensors to study bacterial physiology in the digestive tract
Zhang et al. Milk fat globule membrane protects Bifidobacterium longum ssp. infantis ATCC 15697 against bile stress by modifying global transcriptional responses
Hays et al. Type II fatty acid synthesis pathway and cyclopropane ring formation are dispensable during Enterococcus faecalis systemic infection
Gaudu et al. Genetics of Lactococci
Moon et al. Secretion of recombinant pediocin PA-1 by Bifidobacterium longum, using the signal sequence for bifidobacterial α-amylase